Eurepa MF 1 Tablet
By Eurepa MF
Rx
10 Tablet in a Strip

Composition
Repaglinide(1mg) + Metformin(500mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
April, 2027

liver
When using Eurepa MF 1 Tablet, caution should be taken in patients with liver disease. It may be necessary to adjust the dose of the medication, so it is important to consult your doctor before starting treatment. For patients with mild to moderate liver disease, Eurepa MF 1 Tablet is typically initiated at a low dose to ensure safety. However, the use of this medication is not advised for patients with severe liver disease. Make sure to discuss your liver condition with your healthcare provider before taking Eurepa MF 1 Tablet.

kidney
Eurepa MF 1 Tablet requires caution in patients with kidney disease. Dosage adjustment might be necessary, so consult your doctor. Avoid using Eurepa MF 1 Tablet in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is unsafe to drink alcohol while taking Eurepa MF 1 Tablet.

driving
If you experience symptoms of low or high blood sugar while using Eurepa MF 1 Tablet, avoid driving as it may affect your ability to drive safely.

pregnancy
Eurepa MF 1 Tablet should be used with caution during pregnancy. Limited human studies suggest potential harm to the baby based on animal studies. Your doctor will evaluate the benefits and risks before prescribing. Kindly consult your doctor.

breastfeeding
Eurepa MF 1 Tablet is likely safe during breastfeeding based on limited human data. The drug does not appear to pose a significant risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹196.78
₹231.5
15% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025










